Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Kidney cancer, Renal cell cancer
Closed
Phase 2
This trial is looking at a drug called nivolumab for a type of kidney cancer called renal cell cancer. The trial is for people whose kidney cancer has grown outside the kidney or has spread to another part of their body and who haven’t had any treatment yet.
Recruitment start: 15 April 2015
Recruitment end: 30 April 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr James Larkin
Bristol-Myers Squibb
The Royal Marsden NHS Foundation Trust
Last reviewed: 01 Jun 2022
CRUK internal database number: 11763